RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$783M
AUM Growth
+$86.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
120
New
Increased
Reduced
Closed

Top Buys

1
+$14.5M
2
+$12.9M
3
+$11.6M
4
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$10.1M
5
GKOS icon
Glaukos
GKOS
+$9.98M

Top Sells

1
+$15M
2
+$13.8M
3
+$11.6M
4
NVCR icon
NovoCure
NVCR
+$10.9M
5
BIIB icon
Biogen
BIIB
+$8.3M

Sector Composition

1 Healthcare 89.3%
2 Financials 1.39%
3 Technology 0.15%
4 Energy 0.13%
5 Consumer Discretionary 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$2M 0.25%
35,000
+4,000
77
$1.75M 0.22%
+119,697
78
$1.12M 0.14%
90,000
+20,050
79
$1.02M 0.13%
+11,111
80
$1M 0.13%
+15,000
81
$725K 0.09%
4,833
-114
82
$562K 0.07%
15,401
83
$539K 0.07%
5,641
+804
84
$513K 0.07%
11,144
+3,426
85
$477K 0.06%
8,653
+1,348
86
$467K 0.06%
5,696
+873
87
$372K 0.05%
10,985
-442,680
88
$357K 0.05%
4,793
89
$340K 0.04%
28,404
90
$335K 0.04%
2,806
91
$307K 0.04%
+9,359
92
$278K 0.04%
5,368
93
$256K 0.03%
1,847
94
– –
-120,000
95
– –
-30,000
96
– –
-35,000
97
– –
-5,179
98
– –
-55,000
99
– –
-55,000
100
– –
-70,000
1 2 3
4
5